Search Result "lestaurtinib"
Personalized Medicine for Pediatric AML: New Targeted Strategies
Ebook: Topics in Anti-Cancer Research
Volume: 1 Year: 2012
Author(s): Riccardo Masetti,Katharina Kleinschmidt,Carlotta Biagi,Andrea Pession
Doi: 10.2174/9781608054787112010012
Bench to Bedside Targeting of FLT3 in Acute Leukemia
Journal: Current Drug Targets
Volume: 11 Issue: 7 Year: 2010 Page: 781-789
Author(s): Keith W. Pratz, Mark J. Levis
FLT3 Inhibition in Acute Myeloid Leukaemia â Current Knowledge and Future Prospects
Journal: Current Cancer Drug Targets
Volume: 20 Issue: 7 Year: 2020 Page: 513-531
Author(s): Francesca L. Hogan,Victoria Williams,Steven Knapper
Second-Generation Protein Kinase Inhibitor â A Focus on Quizartinib, A Promising Targeted Therapy for High-Risk FLT3+ Patients with Acute Myeloid Leukemia
Ebook: Frontiers in Clinical Drug Research - Anti-Cancer Agents
Volume: 5 Year: 2019
Author(s): Xavier Thomas,Etienne Paubelle
Doi: 10.2174/9789811405150119050003
Protein Kinase Inhibitors as Therapeutic Drugs in AML: Advances and Challenges
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 29 Year: 2017 Page: 4303-4310
Author(s): Yuan Ling,Zikang Zhang,Hua Zhang,Zunnan Huang
FLT3 Inhibitors in the Management of Acute Myeloid Leukemia
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17 Issue: 8 Year: 2017 Page: 1028-1032
Author(s): E. Zappone,M. Defina,L. Aprile,G. Bartalucci,A. Gozzetti,M. Bocchia
The Role of FLT3 Kinase as an AML Therapy Target
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 19 Year: 2012 Page: 2758-2765
Author(s): Michal Beffinger,Anna Skwarska
Emerging Targeted Therapies for Pediatric Acute Myeloid Leukemia
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 6 Issue: 3 Year: 2011 Page: 354-366
Author(s): Riccardo Masetti, Katharina Kleinschmidt, Carlotta Biagi, Andrea Pession
Clinical Experience with Antiangiogenic Therapy in Leukemia
Journal: Current Cancer Drug Targets
Volume: 11 Issue: 9 Year: 2011 Page: 1053-1068
Author(s): J. Wellbrock, W. Fiedler
JAK Inhibitors: Pharmacology and Clinical Activity in Chronic Myeloprolipherative Neoplasms
Journal: Current Medicinal Chemistry
Volume: 20 Issue: 9 Year: 2013 Page: 1147-1161
Author(s): J. Trelinski,T. Robak